CLINICAL TRIAL / NCT04155749

Master Protocol for the Phase 1 Study of Cell Therapies in Multiple Myeloma

  • Interventional
  • Recruiting
  • NCT04155749

Master Protocol for the Phase 1 Study of Cell Therapies for the Treatment of Patients With Relapsed Refractory Multiple Myeloma, Including Long-term Safety Follow-up

Master protocol for cell therapy, Phase 1 proof-of-concept studies in relapsed and refractory multiple myeloma and includes long-term safety follow-up.